Harvey County Awards $478 Supplies Contract to Glaxosmithkline Pharmaceuticals (February 2024)
- Disclosed value
- $478.04
- From agenda
- Approved
- Feb 20, 2024
The 30-second brief
The Harvey County Health Department purchased vaccines from GlaxoSmithKline Pharmaceuticals.
Glaxosmithkline Pharmaceuticals holds this supplies contract with Harvey County. Its other public contracts on record include work for Teton County and Monroe County.
See every contract and contact at Harvey County.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Supplies
- Amount
- $478.04
- Document date
- February 20, 2024
- Agency
- Harvey County
- Source document
- harvey_county_board_of_commissioners_meeting_agend.pdf (Agenda)
Glaxosmithkline Pharmaceuticals's other public contracts
More Harvey County contracts
Questions about this contract
Who was awarded the supplies contract by Harvey County?
Glaxosmithkline Pharmaceuticals was awarded this supplies contract by Harvey County, as recorded on February 20, 2024. The contract value is $478.04.
How much is the Glaxosmithkline Pharmaceuticals contract with Harvey County worth?
The Glaxosmithkline Pharmaceuticals contract with Harvey County is valued at $478.04, covering supplies work.
What type of contract is this?
This is a Supplies contract, documented as a agenda record.
Where was this contract approved?
This contract appears in harvey_county_board_of_commissioners_meeting_agend.pdf (Agenda), dated February 20, 2024 from Harvey County. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
Show 2 more questions
What other contracts does Glaxosmithkline Pharmaceuticals hold?
Glaxosmithkline Pharmaceuticals may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
What is Harvey County currently buying?
Explore Harvey County's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.